All materials contained on this site are protected by Korean copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior consent of the JoongAng Ilbo | Tel: 1577-0510
JoongAng Ilbo Co., Ltd. | Address: 48-6 Sangamsan-ro, Mapo-gu, Seoul, Republic of Korea
Business registration number: 110-81-00999 | CEO & Publisher: Park Chang-hee | Executive Editor: Choi Ji-young
Mail order business report number: 2020-Seoul Mapo-3838 | Online newspaper registration No: 서울,아55177
Date of Registration: 2023. 11. 21 | Juvenile Protection Manager: Park Hyunyoung
![This photo, provided by South Korean drug firm Chong Kun Dang Pharmaceutical on Dec. 14, 2020, shows Nafabeltan, which is currently used as a blood anticoagulant and acute pancreatitis treatment. [YONHAP]](https://image.koreajoongangdaily.com/10314616.jpg?imageId=10314616&width=240&height=184&format=webp&format=jpg)